Karol Estrada
Vice President of Translational Genomics, San Francisco, California
Professional Overview
Karol Estrada is an accomplished leader in the field of translational genomics, with extensive expertise in driving innovative research and development initiatives that bridge the gap between genomic data and therapeutic applications. As the Vice President of Translational Genomics at Maze Therapeutics, Karol is responsible for overseeing the company's efforts to leverage genomic insights to develop transformative therapies for complex diseases.
Experience Summary
Current Role
As the Vice President of Translational Genomics at Maze Therapeutics, Karol is spearheading the company's efforts to harness the power of genomics to develop novel treatments. In this role, he is responsible for leading a team of talented researchers and scientists, overseeing the design and execution of innovative research projects, and collaborating with cross-functional partners to drive the translation of genomic discoveries into viable therapeutic candidates.
Career Progression
Prior to joining Maze Therapeutics, Karol held several key leadership positions in the pharmaceutical and biotechnology industries. He served as the Head of Translational Genomics at BioMarin Pharmaceutical Inc., where he played a pivotal role in the development of targeted therapies for rare genetic disorders. Earlier in his career, Karol held roles as the Senior Director of Statistical Genetics at BioMarin and as an Associate Director at Biogen, where he contributed to the advancement of cutting-edge research in the field of genetic medicine.
Karol's research expertise and leadership skills have been recognized through his appointment as an Adjunct Professor at Brandeis University, where he collaborates with faculty and students to drive innovation in the field of translational genomics.
Academic Background
Karol holds a Ph.D. in Genetics and Genomics from the Broad Institute of MIT and Harvard, where he specialized in the development of novel analytical approaches for the interpretation of complex genomic data. His groundbreaking research and contributions to the field have been published in several peer-reviewed journals and have earned him recognition within the scientific community.
Areas of Expertise
- Translational genomics and precision medicine
- Innovative research design and project management
- Cross-functional collaboration and stakeholder engagement
- Talent development and team leadership
- Statistical genetics and bioinformatics
Professional Impact
During his tenure at BioMarin, Karol played a pivotal role in the development of several groundbreaking therapies for rare genetic disorders, including the successful launch of a novel treatment for a debilitating metabolic condition. At Maze Therapeutics, he is leveraging his expertise to drive the company's efforts to translate genomic discoveries into transformative therapies for complex diseases, with a focus on improving patient outcomes and addressing unmet medical needs.
Conclusion
Karol Estrada is a recognized leader in the field of translational genomics, with a proven track record of driving innovative research and development initiatives that have a meaningful impact on patient lives. As the Vice President of Translational Genomics at Maze Therapeutics, he is poised to continue making significant contributions to the advancement of genomic-based therapies, further solidifying his position as a respected authority in the industry.
